194 related articles for article (PubMed ID: 5370228)
1. Behavioural and brain neurohormonal changes produced by acute heat stress in rats: influence of psychopharmacological agents.
Menon MK; Dandiya PC
Eur J Pharmacol; 1969 Dec; 8(3):284-91. PubMed ID: 5370228
[No Abstract] [Full Text] [Related]
2. The effects of some hallucinogenic drugs upon the metabolism of 5-hydroxy-tryptamine in the brain.
Tonge SR; Leonard BE
Life Sci; 1969 Aug; 8(15):805-14. PubMed ID: 5807313
[No Abstract] [Full Text] [Related]
3. Behavioural models of psychosis.
Smythies JR; Johnston VS; Bradley RJ
Br J Psychiatry; 1969 Jan; 115(518):55-68. PubMed ID: 5781961
[No Abstract] [Full Text] [Related]
4. Synergism of imipramine and desmethylimipramine with reserpine in the frog. Interaction with 5-hydroxytryptophan and 2-bromolysergid diethylamide (BOL-148).
Lapin IP; Osipova SV; Uskova NV; Stabrovski EM
Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):37-49. PubMed ID: 5303117
[No Abstract] [Full Text] [Related]
5. Behavioral reaction of rats pretreated with reserpine to LSD-25.
Votava Z; Glisson SN; Himwich HE
Int J Neuropharmacol; 1967 Nov; 6(6):543-7. PubMed ID: 5586670
[No Abstract] [Full Text] [Related]
6. The effect of some psychopharmacological agents on heat stress-induced changes in the glutathione levels of brain and blood in rats.
Varma RR; Khuteta KP; Dandiya PC
Psychopharmacologia; 1968; 12(2):170-5. PubMed ID: 5690501
[No Abstract] [Full Text] [Related]
7. [Monoamine oxidase activity in the tissues of rabbits under acute stress].
Loginova GA
Biull Eksp Biol Med; 1973 Apr; 75(4):18-20. PubMed ID: 4804663
[No Abstract] [Full Text] [Related]
8. A pharmacological analysis of processes underlying differential responding: a review and further experiments with scopolamine, amphetamine, lysergic acid diethylamide (LSD-25), chlordiazepoxide, physostigmine, and chlorpromazine.
Frontali M; Amorico L; De Acetis L; Bignami G
Behav Biol; 1976 Sep; 18(1):1-74. PubMed ID: 791242
[No Abstract] [Full Text] [Related]
9. Facilitation of avoidance behaviour by LSD-25 and mescaline in hamsters.
Sansone M; Castellano C; Messeri P
Pharmacol Res Commun; 1974 Aug; 6(4):369-76. PubMed ID: 4438404
[No Abstract] [Full Text] [Related]
10. Neurochemical correlates of behaviour. Changes in acetylcholine, norepinephrine and 5-hydroxytryptamine concentrations in several discrete brain areas of the rat during behavioural excitation.
Aprison MH; Kariya T; Hingtgen JN; Toru M
J Neurochem; 1968 Oct; 15(10):1131-9. PubMed ID: 5711126
[No Abstract] [Full Text] [Related]
11. 2,5-Dimethoxy-4-methylamphetamine (DOM), a neuropharmacological examination.
Wallach MB; Friedman E; Gershon S
J Pharmacol Exp Ther; 1972 Jul; 182(1):145-54. PubMed ID: 4261221
[No Abstract] [Full Text] [Related]
12. Amphetamine toxicity and brain monoamines in three models of stress.
Goldberg ME; Salama AI
Toxicol Appl Pharmacol; 1969 May; 14(3):447-56. PubMed ID: 5787514
[No Abstract] [Full Text] [Related]
13. Exploring the brain with drugs.
Marrazzi AS
Cond Reflex; 1968; 3(3):181-8. PubMed ID: 4387187
[No Abstract] [Full Text] [Related]
14. Behavioural actions of some substituted amphetamines.
Buxton DA
Prog Brain Res; 1972; 36():171-81. PubMed ID: 4644027
[No Abstract] [Full Text] [Related]
15. Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism.
Tonge SR; Leonard BE
Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):168-76. PubMed ID: 5010826
[No Abstract] [Full Text] [Related]
16. Lack of cross-tolerance in rats among (-)delta9-trans-tetrahydrocannabinol(delta9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25).
Teresa M; Silva A; Carlini EA; Claussen U; Korte F
Psychopharmacologia; 1968; 13(4):332-40. PubMed ID: 5722169
[No Abstract] [Full Text] [Related]
17. Some metabolic and behavioural effects of LSD.
Kabes J; Fink Z; Somlev A; Vrba J; Mádlo Z
Act Nerv Super (Praha); 1972 Nov; 14(4):294-5. PubMed ID: 5083833
[No Abstract] [Full Text] [Related]
18. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
Andén NE
Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
[No Abstract] [Full Text] [Related]
19. Serotonin and behavioral inhibition.
Stein L; Wise CD
Adv Biochem Psychopharmacol; 1974; 11(0):281-91. PubMed ID: 4276861
[No Abstract] [Full Text] [Related]
20. Molecular pharmacology of hallucinogens.
Johnston VS; Bradley RJ
Recent Adv Biol Psychiatry; 1968; 10():74-99. PubMed ID: 4872761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
